Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

BACKGROUND: The focus of this study is to identify particular microRNA (miRNA) signatures in exosomes derived from plasma of 435 human epidermal growth factor receptor 2 (HER2)-positive and triple-negative (TN) subtypes of breast cancer (BC). METHODS: First, miRNA expression profiles were determined...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevic, Ines, Müller, Volkmar, Weber, Karsten, Fasching, Peter A., Karn, Thomas, Marmé, Frederic, Schem, Christian, Stickeler, Elmar, Denkert, Carsten, van Mackelenbergh, Marion, Salat, Christoph, Schneeweiss, Andreas, Pantel, Klaus, Loibl, Sibylle, Untch, Michael, Schwarzenbach, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178264/
https://www.ncbi.nlm.nih.gov/pubmed/30301470
http://dx.doi.org/10.1186/s12916-018-1163-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178264/
https://www.ncbi.nlm.nih.gov/pubmed/30301470
http://dx.doi.org/10.1186/s12916-018-1163-y

Ejemplares similares